Tag archive for ‘Johnson Johnson’
Ilan Shavit On Tuesday, May 3rd, 2016

Johnson & Johnson Faces 1, 000 More Talc-Cancer Suits After Verdict Loss of $55 million

A jury has awarded $55 million to a woman who blamed Johnson & Johnson blamed her ovarian cancer on their talcum powder in the second such trial loss this year. According to Bloomberg  J&J is accused More...

Reuters On Wednesday, December 3rd, 2014

Exclusive: J&J hires Goldman to explore sale of Splenda – sources

– U.S. healthcare company Johnson & Johnson has hired Goldman Sachs to explore a sale of its artificial sweetener brand Splenda, sources familiar with the matter told Reuters. Such a move would let More...

Vered Weiss On Monday, December 1st, 2014

3 Stocks Gurus Are Selling

Billionaire investors are ditching Neflix, Johnson & Johnson and Celgene. Motley Fool writers Leo Sun, George Budwell and Cheryl Swanson discuss the reasons why. Carl Icahn is selling Netflix, and More...

Vered Weiss On Sunday, November 2nd, 2014

5 Boring Stock Picks from Phil Davidson

Phil Davidson of American Century likes boring but solid stocks, as reported by Seeking Alpha. He tends to prefer stocks that have solid balance sheets and are in industries that are stable but boring, because More...

Vered Weiss On Tuesday, August 5th, 2014

Ken Fisher’s Top 4 Holdings

– Ken Fisher is one of the most successful money managers around; for the year, his holdings increased in value from $44.3 billion to $47.6 billion. Ken Fisher’s portfolio currently has a total More...

Clive Minchom On Friday, January 17th, 2014

David Rubenstein’s Carlyle Group Buying Diagnostics Division Of Johnson & Johnson For $4.15 Billion

– – Global alternative asset manager The Carlyle Group, which is chaired by founder David Rubenstein, has just cut a firm deal to buy the ortho-clinical diagnostics (OCD) division of Johnson More...

Clive Minchom On Sunday, November 10th, 2013

Rales Brothers Danaher Corp Rumoured To Bid $4 Billion For J&J’s Diagnostics Division

– On January 22nd last, Johnson & Johnson presented to the world its review of business strategy for its Medical Devices & Diagnostics group. This collection of businesses, with annual sales More...

Contributor On Tuesday, June 11th, 2013

Johnson&Johnson, OrbiMed, AstraZeneca and Takeda to bid for Israeli biotech incubator

– AstraZeneca and Japan’s Takeda will bid against Johnson & Johnson and OrbiMed for the Chief Scientist’s tender. – – /By Gali Weinreb / UK pharmaceutical company AstraZeneca More...

Contributor On Friday, May 31st, 2013

Novocure : breakthrough in brain tumor treatment

– Novocure CEO Asaf Danziger says the company will remain independent, despite interest from big pharma. – – /By Gali Weinreb / Novocure Ltd. may be the most successful Israeli life sciences More...

פטיש LAW court Illustration

Lawsuit: Disintegrating Artificial Hip a Major Headache for Johnson & Johnson

– / By Itzhak Dannon / Sixty three recipients of an artificial hip made by J.C. Health Care (a subsidiary of the giant U.S. corporation Johnson & Johnson and a world leader in the fields of medicine More...

Wordpress site Developed by Fixing WordPress Problems